Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic Patients
Phase of Trial: Phase IV
Latest Information Update: 09 May 2019
Price : $35 *
At a glance
- Drugs Denosumab (Primary) ; Teriparatide
- Indications Osteoporosis
- Focus Therapeutic Use
- 19 May 2015 Planned primary completion date changed from 1 Sep 2014 to 1 May 2015, as reported by ClinicalTrials.gov.
- 21 Oct 2014 According to ClinicalTrials.gov, the protocol has been modified to include subjects ≥ 1 year and exclusion criteria are also modified.
- 05 Sep 2014 Planned primary completion date changed from 1 May 2014 to 1 Sep 2014 as reported by ClinicalTrials.gov record.